TAB. MELKERAN 2 MG

TAB. MELKERAN 2 MG
Product Description

- PALLIATIVE TREATMENT OF MULIPLE MYELOMA.- PALLIATION OF NON - RESECTABLE EPITHELIAL CARCINOMA OF THE OVARY .

RMPL Pharma LLP

  • IN
  • 2018
    On CPHI since
  • 1 - 24
    Employees
Company types
Pharmaceutical company
Wholesale/Retail
Specifications

RMPL Pharma LLP

  • IN
  • 2018
    On CPHI since
  • 1 - 24
    Employees
Company types
Pharmaceutical company
Wholesale/Retail

More Products from RMPL Pharma LLP (99)

  • Inj. Canzatax 100 mg

    Product Inj. Canzatax 100 mg

    Inj. Paclitaxel 100 mg
  • INJ. CARMENDAN 12.5 MG

    Product INJ. CARMENDAN 12.5 MG

    LIVOSIMENDAN 12. MG INJECTION.
  • Inj. Melkeran 50 mg

    Product Inj. Melkeran 50 mg

    Inj. Melphalan 50 mg
  • Tab. Low-K

    Product Tab. Low-K

    POTASSIUM CHLORIDE TABLETS
  • Ves-ATRA Softgel

    Product Ves-ATRA Softgel

    Tretinoin Soft Gelatin Capsules.
  • INJ. MELKERAN 50 MG

    Product INJ. MELKERAN 50 MG

    - PALLIATIVE TREATMENT OF MULIPLE MYELOMA.- PALLIATION OF NON - RESECTABLE EPITHELIAL CARCINOMA OF THE OVARY .
  • INJ.LEUCOVORIN  CALCIUM 50 MG

    Product INJ.LEUCOVORIN CALCIUM 50 MG

    - AN ACTIVE METABOLITE OF FOLIC ACID  ( ALSO CALLED  FOLINIC ACID AND CICTROVORUM FACTOR ), WHICH DOSE NOT REQUIRE METABOLISM BY DIHYDROFOLATE REDUCTASE , THE MOLECULAR TARGET OF FOLATE ANTAGONIST- TYPE CHEMOTHERAPEUTIC DRUGS.
  • INJ. HOLOFOS 2 MG

    Product INJ. HOLOFOS 2 MG

    - INDICATED FOR USE IN COMBINATION WITH CERTAIN OTHER APPROVED ANTI NEOPLASTIC AGENT FOR THIRD - LINE CHEMOTHERAPY OF GERMS CELL TESTICULAR CANCER.- IFOSFAMIDE IS COMBINED IS COMBINED WITH MESNA FOR PROPHYLAXIS OF HEMORRHAGIC CYSTITIS.
  • INJ. HOLOFOS 1 GM

    Product INJ. HOLOFOS 1 GM

    - INDICATED FOR USE IN COMBINATION WITH CERTAIN OTHER APPROVED ANTI NEOPLASTIC AGENT FOR THIRD - LINE CHEMOTHERAPY OF GERMS CELL TESTICULAR CANCER.- IFOSFAMIDE IS COMBINED IS COMBINED WITH MESNA FOR PROPHYLAXIS OF HEMORRHAGIC CYSTITIS.
  • INJ. 5 - FLU 500 MG

    Product INJ. 5 - FLU 500 MG

    USE IN - PALLIATIVE MANAGEMENT OF CARCINOMA OF THE COLON , RECTUM , BREAST , STOMACH AND PANCREAS.
  • INJ. 5 - FLU 250 MG

    Product INJ. 5 - FLU 250 MG

    USE IN - PALLIATIVE MANAGEMENT OF CARCINOMA OF THE COLON , RECTUM , BREAST , STOMACH AND PANCREAS.
  • TAB. ARIMIZOLE 1 MG

    Product TAB. ARIMIZOLE 1 MG

     - ANASTRAZOLE  IS USE FOR ADJUTANT TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER.- FOR THE FIRST LINE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE OR HORMONE RECEPTOR UNKNOWN LOCALLY ADVANCED OR METASTATIC BREAST CANCER.
    - FOR THE TRE...

RMPL Pharma LLP resources (1)

  • Brochure RMPL PHARMA LLP.

    The primary goal of RMPL PHARMA LLP. is to supply our consumers with pharmaceutical products by providing assurance regarding their performance safety, value and consistency. The commitment to quality is well rooted in corporate values of our company and is very essential to our continuous development & success.